← Back to Fund Radar

Fund page

GVC GAESCO CROSSOVER, FI

Category
—
Latest period
H2 2025
Positions
15

Portfolio as of 2025-12-31. Source: periodic filing with the CNMV. View original filing (PDF)

Full portfolio

Every position in the latest periodic filing, largest weight first. Aggregates ("other equities...") are baskets of small positions the filing itself does not break out line by line.

15
Company Type Country Weight Price
ESTADO ESPAÑOL ES0L02602065 · EUR Deuda Publica Cotizada Memos 1 Anio ES 12.98% —
ESTADO ESPAÑOL ES0L02601166 · EUR Deuda Publica Cotizada Memos 1 Anio ES 5.17% —
ESTADO ESPAÑOL ES0L02601166 · EUR Deuda Publica Cotizada Memos 1 Anio ES 2.60% —
ESTADO ESPAÑOL ES0L02601166 · EUR Deuda Publica Cotizada Memos 1 Anio ES 2.59% —
ESTADO ESPAÑOL ES0L02601166 · EUR Deuda Publica Cotizada Memos 1 Anio ES 2.59% —
Acciones|EVOTEC AG DE0005664809 · EUR Renta Variable Cotizada DE 0.04% 2.57 EUR
Acciones|WENDEL FR0000121204 · EUR Renta Variable Cotizada FR 0.04% 82.25 EUR
Acciones|RHEINMETALL AG DE0007030009 · EUR Renta Variable Cotizada DE 0.04% 1090.20 EUR
Acciones|HIKMA PHARMACEUTICALS PLC GB00B0LCW083 · GBP Renta Variable Cotizada GB 0.04% 1662.00 GBp
Acciones|CELLNEX TELECOM SAU ES0105066007 · EUR Renta Variable Cotizada ES 0.04% 25.62 EUR
Acciones|WOLTERS KLUWER NV NL0000395903 · EUR Renta Variable Cotizada NL 0.04% 81.52 EUR
Acciones|HEINEKEN HOLDING NV NL0000008977 · EUR Renta Variable Cotizada NL 0.04% 72.30 EUR
Acciones|REED INTERNATIONAL GB00B2B0DG97 · GBP Renta Variable Cotizada GB 0.04% 2914.00 GBp
Acciones|GRIFOLS ES0171996087 · EUR Renta Variable Cotizada ES 0.04% 10.18 EUR
Acciones|ALTEN FR0000071946 · EUR Renta Variable Cotizada FR 0.04% 84.00 EUR

This period's moves

H2 2025 vs H1 2025 (estimated)

New: 8 Exits: 19 Increases: 0 Cuts: 4
+ ESTADO ESPAÑOL

Enters the portfolio at 12.98% weight.

View company page →
+ ESTADO ESPAÑOL

Enters the portfolio at 2.59% weight.

View company page →
+ Acciones|EVOTEC AG

Enters the portfolio at 0.04% weight.

Evotec SE operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally. It operates in two segments, Shared R&D and Just – Evotec Biologics. The company is developing pharmaceutical products in various therapeutic areas, such as oncology, autoimmune, cancer, diabetes, heart failure, immunology, pain and inflammation, infectious, kidney, liver, respiratory, fibrotic and metabolic diseases, and rare diseases. It is also developingcentral nervous system (CNS) and cardiometabolic diseases; and animal and women health. The company has collaboration agreements with Mass General Brigham and Joslin Diabetes Center focusing on cardiometabolic diseases; BMS antiviral; Novo Nordisk cell therapy; University of Oxford; German Cancer Research Center; University Hospital in Hamburg; University of Toronto, Harvard, and Yale; Johns Hopkins University; Ospedale San Raffaele (OSR); and National University of Singapore. In addition, it has a partnership with LAB282, LAB150, beLAB2122, beLAB1407, LAB eN², Danube Labs, VC Amplitude Ventures, LaB eN2, and 65LAB. Further, the company serves pharma and biotechnology companies, academic institutions, patient advocacy groups, and venture capital. Evotec SE has strategic collaboration with Almirall, S.A. for the development of novel therapeutics for severe skin diseases, including a range of immune-mediated inflammatory conditions. The company collaborate with Odyssey Therapeutics, Inc. to designs and develops AI based discovery platform to discover new treatments in autoimmune and inflammatory diseases. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.

View company page →
+ Acciones|RHEINMETALL AG

Enters the portfolio at 0.04% weight.

Rheinmetall AG provides mobility and security technologies in Germany, Rest of Europe, North, Middle, and South America, Asia and the Near East, and internationally. The company operates through the Vehicle Systems, Weapon and Ammunition, and Electronic Solutions segments. Its Vehicle Systems segment offers combat, logistics, support, and special vehicles, including armored tracked vehicles, CBRN protection systems, artillery, turret systems, and wheeled logistics and tactical vehicles. The Weapon and Ammunition segment provides firepower and protection solutions, such as weapons and ammunition, protection systems, propellants, and international projects and services. Its Electronic Solutions segment offers a chain of systems network, such as sensors, networking platforms, automated connected effectors for soldiers, cyberspace protection solutions, and training and simulation solutions. The company's products include air defense, soldier, and fire control systems; radar technology; and command, control and reconnaissance systems, as well as simulations for the army, air force, navy, and civil applications. It also engages in the aftermarket activities. The company was formerly known as Rheinmetall Berlin AG and changed its name to Rheinmetall AG in 1996. Rheinmetall AG was founded in 1889 and is headquartered in Düsseldorf, Germany.

View company page →
+ Acciones|HIKMA PHARMACEUTICALS PLC

Enters the portfolio at 0.04% weight.

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products. The company operates through three segments: Injectables, Hikma Rx, and Branded. The Injectables segment provides generic and specialty injectable products primarily for use in hospitals. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The Hikma Rx segment offers oral, respiratory, and other generic and specialty products for the retail market. It provides its products in various therapeutic areas, including respiratory, oncology, and pain management. The company also offers its products in solid, semi-solid, liquid, and injectable dosage forms. It operates in the United Kingdom, Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, United Kingdom.

View company page →
+ Acciones|WOLTERS KLUWER NV

Enters the portfolio at 0.04% weight.

Wolters Kluwer N.V. provides information, software solutions, and services for professionals in the Netherlands, rest of Europe, the United States, Canada, the Asia Pacific, and internationally. The company operates through Health; Tax & Accounting; Financial & Corporate Compliance; Legal & Regulatory; and Corporate Performance & ESG segments. The Health segment offers clinical solutions and develops GenAI and agentic solutions to drive better patient care and health outcomes. It serves hospitals, healthcare organizations, clinicians, students, schools, libraries, payers, life sciences, digital health companies, and pharmacies. The Tax & Accounting segment offers AI-powered, cloud-based and on-premise software suites, research solutions to tax and accounting firms; and professional services to support professional workflows, including compliance, audit, and firm management. It also serves businesses, government agencies, and academia. The Financial & Corporate Compliance segment provides financial institutions, corporations, small businesses, and law firms with solutions that enable compliance with ever-changing regulatory and legal obligations, improve efficiency, and help achieve better business outcomes. The Legal & Regulatory segment provides Legal & Regulatory trusted information, insights, and analytics for optimal decisions with accuracy and speed. It serves legal and compliance professionals in law firms, corporate legal departments, universities, and government organizations. The Corporate Performance & ESG segment offers delivers software solutions that support organizations in planning, simulating, and managing financial, sustainability, operational, and risk management activities to drive better outcomes. The company also develops a hosted platform for managing and controlling external legal costs. Wolters Kluwer N.V. was founded in 1836 and is headquartered in Alphen aan den Rijn, the Netherlands.

View company page →
+ Acciones|REED INTERNATIONAL

Enters the portfolio at 0.04% weight.

RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk, as well as a portfolio of commercial healthcare products. Its Scientific, Technical & Medical segment provides scientific and medical information and data sets for science and healthcare. The Legal segment provides legal, regulatory, and business information and analytics. Its Exhibitions segment combines digital tools and data to help customers connect in-person and online, discover new markets, source products, generate leads, and transact. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. RELX PLC was incorporated in 1903 and is headquartered in London, the United Kingdom.

View company page →
+ Acciones|ALTEN

Enters the portfolio at 0.04% weight.

Alten S.A. operates as an engineering and technology consultancy company in France, North America, Germany, Scandinavia, Benelux, Iberian, Italy, the United Kingdom, the Asia-Pacific, Switzerland, Eastern Europe, and internationally. It undertakes projects for the technical, research and development, and information systems divisions of industrial, telecoms, and service clients. The company also provides engineering services, such as mechanic and materials, data management, systems engineering and PDM, project management office, quality assurance, manufacturing, environment, health and safety, electronics; embedded software; and construction infrastructure services. In addition, it provides IT services comprising AMOA and business analyst; cybersecurity; artificial intelligence; application software; data management; green IT; software testing and QA; and cloud and infrastructure services. The company serves customers in aeronautics, space, defense and naval, security, automotive, rail and mobility, energy and environment, life sciences and health, banking, industrial equipment and electronics, banking, finance and insurance, telecoms, retail, services, media, and public sectors and government services. Alten S.A. was incorporated in 1988 and is headquartered in Boulogne-Billancourt, France.

View company page →
− ESTADO ESPAÑOL

Leaves the portfolio; it was 2.68% of weight.

− ESTADO ESPAÑOL

Leaves the portfolio; it was 2.67% of weight.

− ESTADO ESPAÑOL

Leaves the portfolio; it was 2.67% of weight.

− ESTADO ESPAÑOL

Leaves the portfolio; it was 2.67% of weight.

− ESTADO ESPAÑOL

Leaves the portfolio; it was 2.67% of weight.

− ESTADO ESPAÑOL

Leaves the portfolio; it was 2.66% of weight.

− Acciones|FORVIA

Leaves the portfolio; it was 1.87% of weight.

Forvia SE, together with its subsidiaries, manufactures and sells automotive technology solutions in France, Germany, other European countries, other Europe, the Middle East, Africa, the Americas, Asia, and internationally. It operates through Seating, Interiors, Clean Mobility, Electronics, Lighting, and Lifecycle Solutions segments. The Seating segment designs and manufactures vehicle seats, seating frames, and adjustment mechanisms. The Interiors segment designs, manufactures, and assembles instrument panels, door panels, and modules. The Clean Mobility segment designs and manufactures exhaust systems, solutions for fuel cell electric vehicles, and aftertreatment solutions for commercial vehicles. The Electronics segment designs and manufactures display technologies, driver assistance systems, and cockpit electronics, including HELLA electronics and Clarion electronics. The Lighting segment designs and manufactures lighting technologies. The Lifecycle Solutions segment provides solutions extending the vehicle lifecycle, as well as workshop equipment and special original equipment. The company was formerly known as Faurecia S.E. and changed its name to Forvia SE in June 2023. Forvia SE was founded in 1914 and is headquartered in Nanterre, France.

View company page →
− Acciones|SR TELEPERFORMANCE

Leaves the portfolio; it was 1.39% of weight.

Teleperformance SE, together with its subsidiaries, operates as a digital business services company in France and internationally. The company operates in Core Services and Specialized Services segments. The company offers customer relationship, technical assistance, and customer acquisition services; business processes management, and back office and digital platform services; online interpretation, visa application management, health management, recruitment process outsourcing advisory and assistance, and accounts receivable credit management services. It also provides digital CX, trust and safety, artificial intelligence, real-time speech understanding, StoryfAI application, TP microservices, and video CX; back-office processing, integrated sales, finance and accounting, smartshoring, work-at-home, multilingual services, ad sales, and rebadging solutions; advanced analytics, business process optimization, business transformation consulting, and technology services; and claims management, collection services, interpretation and translation, recruitment process outsourcing, visa and consular services, and healthcare support. The company serves automotive, energy and utilities, media, government, technology, travel, hospitality, cargo, banking and financial services, healthcare, insurance, retail and e-commerce, telecom, and video games industries. The company was incorporated in 1910 and is based in Paris, France.

View company page →
− Acciones|RWE

Leaves the portfolio; it was 0.72% of weight.

RWE Aktiengesellschaft generates and supplies electricity from renewable and conventional sources in Germany, the United Kingdom, rest of Europe, North America, and internationally. It operates through five segments: Offshore Wind; Onshore Wind/Solar; Flexible Generation; Supply & Trading; and Phaseout Technologies. The company generates wind, hydro, solar, gas, lignite, and biomass electricity. It also trades in electricity, gas, and energy commodities; operates gas storage facilities; and engages in battery storage activities, as well as lignite mining and refining. The company serves commercial, industrial, and municipal customers. RWE Aktiengesellschaft was founded in 1898 and is headquartered in Essen, Germany.

− Acciones|RENAULT

Leaves the portfolio; it was 0.70% of weight.

Renault SA engages in the design, manufacture, sale, repair, maintenance, and leasing of motor vehicles in Europe, Eurasia, Africa, the Middle East, the Asia Pacific, and the Americas. The company operates through Automotive, Sales Financing, and Mobility Services segments. The Automotive segment produces, sells, and distributes passenger cars and light commercial vehicles. The Sale Financing segment is involved in the sales financing, rental, maintenance, and service contracts under the Mobilize Financial Services trade name. The Mobility Services segment provides mobility and energy solutions for electric vehicle users under the Mobilize Beyond Automotive brand. It offers used vehicles and spare parts; and engages in the business-to-business powertrain activities, and research and advanced engineering activities. The company also engages in the design and production of parts and equipment used for manufacturing and operation of vehicles. It serves commercial, light commercial and passenger vehicles, tractors, farm machinery and construction equipment under the Renault, Dacia, and Alpine brands. The company was founded in 1898 and is based in Boulogne-Billancourt, France.

View company page →
− Acciones|SEB SA

Leaves the portfolio; it was 0.68% of weight.

SEB SA designs, manufactures, and markets small domestic equipment in Western Europe, rest of Europe, the Middle East, Africa, North and South America, China, and rest of Asia. It operates through Consumer Business and Professional Business segments. The company provides flagship products, such as cookeo, rice cooker IH spherical, optiGrill, garment steamer, thermal-spot titanium pro fumeless wok, and crep maker billig products. It also offers electrical cooking, food preparation, and beverage preparation products, such as deep fryers, rice and pressure cookers, informal meal appliances, waffle makers, grills, toasters, multicookers, filter and pod coffee makers, espresso machines, kettles, home beer-taps, soymilk makers, blenders, cooking food processors, kitchen and juice machines, mixers, beaters, countertop ovens, and induction hobs. In addition, the company provides linen, home and personal care products that include irons and steam generators, garment steamers, canister vacuum cleaners with or without dust bag, steam and upright vacuum cleaners, vacuum weepers, fans, heaters, air treatment and hair care appliances, depilators, and bathroom scales. Further, it offers frying pans, saucepans pots, bakeware, food storage containers, carafes, flasks, thermo mugs, cutlery, and kitchen utensils. Additionally, the company designs, produces, and markets crepe and waffle makers, planchas, and grills for professionals and consumers. It sells its products under the Arno, Asia Vina, Calor, Clock, DASH, EMSA, imusa, Kaiser, Krupus, Maharaj Whiteline, MIRRO, Moulinex, OBH NORDICA, PANEX, PEBBLY, Rochedo, Rowenta, Samurai, Seb, SUPOR, Tefal T-fal, umco, WearEver, 32 DUMAS, All-Clad, de Buyer, Krampouz, LACANCHE, Lagostina, Open'Cook, SABATIER, Silit, WMF, and Forge Adour, Air'T, Ambassade de Bourgogne, Charvet, HEPP, La San Marco, Pacojet, Scaritech, Schaerer, Wilbur Curtis, and Zummo brands. SEB SA was founded in 1857 and is headquartered in Ecully, France.

View company page →
− Acciones|MERCK KGA

Leaves the portfolio; it was 0.67% of weight.

Merck KGaA operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific. The Life Science segment offers products, solutions, and services to academic, research and diagnostic labs, biotech, and pharmaceutical companies, as well as the industrial sector; reagents, consumables, devices, instruments, software, and services for research, production, and testing to lab water instruments, microbiology and biomonitoring products, test assays, analytical reagents, and flow cytometry kits and instruments. This segment also provides traditional and novel therapies, such as ration devices, chromatography resins, single-use systems, process chemicals, and excipients for bioprocessing; contract development, manufacturing and testing services, which supports customers from preclinical phases to commercialization. The Healthcare segment discovers, develops, manufactures, and markets prescription drugs and biopharmaceuticals to the therapeutic areas of oncology, rare diseases, neurology and immunology, fertility, cardiovascular, and metabolic and endocrinological disorders. The Electronics segment offers advanced dielectric and metallic materials; photoresist, anti-reflective coating, and material lithography products; clean and selective etch chemistries; materials for chemical-mechanical planarization; high-purity gases for semiconductor manufacturing; and develops and installs delivery equipment for handling of specialty chemicals and gases for semiconductor manufacturing; develops modulating, creating, engineering, and guiding light; and material solutions in liquid crystals, OLED materials, and photoresists. It has in-licensing agreement with Abbisko Therapeutics Co. Ltd., China on drug candidates for the treatment of tenosynovial giant cell tumor; and strategic partnership with Versant Ventures to advance treatments for rare genetic cardiomyopathies. The company was founded in 1668 and is headquartered in Darmstadt, Germany. Merck KGaA operates as a subsidiary of E. Merck KG.

− Acciones|EDENRED

Leaves the portfolio; it was 0.67% of weight.

Edenred SE operates as a digital platform for services and payments for companies, employees, and merchants worldwide. It offers employee benefit solutions, including Ticket Restaurant, a solution that allows employees to take time out for lunch at a partner merchant; Ticket Alimentación, which allows users to pay for groceries in stores and supermarkets; Edenred Regalo, a gift voucher; Ticket CESU, a human services solution; Edenred City, a solution that enables the purchase of staples, such as food and fuel; Welfare Edenred, which employees can use to pay for various services, including access to sports facilities and solutions for their children's educational needs; Edenred Eco, a solution that encourages the purchase of environmentally friendly products in Belgium; and Kadéos Culture in France and Ticket Cultura in Brazil for cultural goods and services, as well as mobility solutions through Edenred Mobility. The company also offers mobility solutions comprising Ticket Car for employees to pay for fuel and other business travel expenses; Empresarial, which enables companies to control spending to reimburse expense claims; Cintelink, a smart cloud platform for service stations and commercial fleets; UTA Edenred, a fuel card; Ticket Fleet Pro for truck fleet management; Edenred Finance that provides refund services to European transportation companies; The Right Fuel Card, a fuel card manager; and Spirii, a platform for recharging electric vehicles. In addition, it provides complementary solutions comprising corporate payment, incentive and rewards, salary card solutions; and benefits and engagement programs. Edenred SE was founded in 1962 and is headquartered in Issy-les-Moulineaux, France.

View company page →
− Acciones|PRUDENTIAL CORP

Leaves the portfolio; it was 0.45% of weight.

Prudential plc, through its subsidiaries, provides life and health insurance, and asset management solutions to individuals in Asia and Africa. It offers savings and investments products; and wealth, health, and protection products. The company was founded in 1848 and is headquartered in Central, Hong Kong.

− Acciones|BOLLORE

Leaves the portfolio; it was 0.40% of weight.

Bolloré SE engages in the transportation and logistics, communications, and industry businesses in France, rest of Europe, the Americas, the Asia-Pacific, and Africa. The company operates through Bolloré Energy, Communications, and Industry segments. It is involved in distribution and warehousing of oil products, as well as domestic fuel oil and transport and other diesel. The company also engages in the publishing and distribution of pay and free TV and production; sale and distribution of cinema films and TV series; design and release of downloadable video games on mobile devices and consoles; ticketing and venue services; communications consulting and advertising agencies; magazine sales; sales of goods and circulation of publications; travel retail sales; and sales of licenses and subscription services. In addition, it is involved in production and sale of electric batteries and their applications; and electric vehicles, and electricity storage and solutions and films. The company was founded in 1822 and is based in Puteaux, France. Bolloré SE operates as a subsidiary of Compagnie de l'Odet.

View company page →
− Acciones|EURAZEO

Leaves the portfolio; it was 0.39% of weight.

Eurazeo SE is a private equity and venture capital firm specializing in growth capital, series C, acquisitions, leveraged buyouts, and buy-ins of a private company, and investments in upper mid-market, mid-market and listed public companies, small- and mid-cap healthcare companies, equity in the small-mid and mid-large buyout segments. The firm seeks to invest in medium-sized or large companies, SMEs, high growth companies, and real estate management and investment activities. It does not have any restrictions regarding the sectors in which it invests but prefers to invest in smart cities, services, leisure and mobility, real estate, fintech, investment activities, distribution, industry, luxury, consumer goods, business services, consumer and retail brands, and health sectors. The firm seeks to invest in consumer brands with a focus on beauty, digital health, life science, tech, financial services, personal care, household care, juvenile products, apparel, wellness, accessories, home, jewellery, leisure, health, fitness, beverage, and food companies based in United States and Europe. It typically invests in companies with a differentiated concept and global growth potential. The firm identifies companies upstream, carefully selecting them primarily from sectors driven by digital transformation and focusing on changes in lifestyle and consumption (mobility, online buying, collaboration models, etc. The firm invests in large properties in need of restructuring; residential, commercial, and office development projects; and companies with real estate assets in Western Europe. It primarily invests in New York, United States, Paris, France, Italy, North America, China and other European countries. It seeks to invest between €50 million ($54.35 million) to €250 million ($271.77 million) in small mid buyout business. It seeks to invest between €25 million ($27.18 million) and€100 million ($108.71 million) in growth business. It seeks to invest between €10 million ($10.82 million) and €40 million ($43.82 million) in the fields of healthcare research. It seeks to invests between equity investment between €1 million ($1.17 million) and €559.01 million ($600 million) with sales value between €10 million ($11.28 million) and €200 million ($211.73 million) and enterprise value is between €20 million ($21.22 million) and €5000 million ($5366.62 million) in between mid-large buyout enterprise value is between €500 million ($541.94 million) and €1.5 billion ($1625.82 million) and in small mid buyout enterprise value is between €100 million ($108.39 million) and €500 million ($541.94 million). It prefers to makes debt investment between €5 million ($5.37 million) and €100 million ($107.33 million) in between leveraged loans funding between €10 million ($10.73 million) and €50 million ($53.67 million) per transaction. It limits each investment to less than 10 percent to 15 percent of its net asset value. The firm prefers to make investments with transactions above $100 million as co-investments. It prefers to acquire majority stakes in its portfolio companies along with minority stakes. The firm may invest in public companies either taking the public company to private, and then doing a leveraged buyout or in the form of private investment in public equity (PIPE). The firm invests for a period of five to seven years. It exits its investment by sale to a manufacturer, sale to a financial investor, or through an IPO. Eurazeo SE was founded in 1969 and is based in Paris, France with additional offices in North America, Asia, Europe and South America.

View company page →
− Acciones|UBI SOFT ENTERTAINMENT SA

Leaves the portfolio; it was 0.38% of weight.

Ubisoft Entertainment SA produces, publishes, distributes, and operates video games for consoles, PC, smartphones, and tablets in physical and digital formats in Europe, North America, and internationally. It designs and develops software, including scenarios, animation, gameplay, layouts, and game rules, as well as design tools and game engines. The company was incorporated in 1986 and is headquartered in Saint-Mandé, France.

− Acciones|INCHCAPE PLC

Leaves the portfolio; it was 0.37% of weight.

− Acciones|GLENCORE INTERNATIONAL WI

Leaves the portfolio; it was 0.27% of weight.

Glencore plc engages in the production, refinement, processing, storage, transport, and marketing of metals and minerals, and energy products in the Americas, Europe, Asia, Africa, and Oceania. The company operates in two segments, Marketing Activities and Industrial Activities. It engages in the production and marketing of copper, cobalt, lead, nickel, zinc, chrome ore, ferrochrome, vanadium, aluminum, alumina, and iron ore; and coal, crude oil, refined products, and natural gas, as well as oil exploration and production and refining and distribution. The company is also involved in marketing and distributing physical commodities sourced from third party producers to industrial consumers, including the battery, electronic, construction, automotive, steel, energy, and oil industries. In addition, the company provides financing, logistics, and other services to producers and consumers of commodities. Glencore plc was founded in 1974 and is headquartered in Baar, Switzerland.

View company page →
▼ Acciones|WENDEL

Goes from 0.78% to 0.04%.

Wendel is a private equity firm specializing in equity financing in middle markets and later stages through leveraged buy-out and transactions and acquisitions. It invests in both listed and non-listed companies. The firm also invest in private debt and secondary. The firm typically invests in btob, education technology, energy transition, technology services, software, business services, healthcare, and industrial technology. The firm seeks to invest in Africa, Europe, European Developed Markets, Western Europe, particularly France, and North America (United States and Canada). It invests between 300 million ($354.04 million) and 800 million ($944.12 million). It targets majority/control/large minority investments in listed or unlisted companies. The firm seeks to take a seat on the board of directors or supervisory board and key committees of its portfolio companies. It makes balance sheet investments. Wendel was founded in 1704 and is headquartered in Paris, France with additional offices across Asia, North America, United Kingdom and Europe.

View company page →
▼ Acciones|CELLNEX TELECOM SAU

Goes from 0.73% to 0.04%.

Cellnex Telecom, S.A. engages in the management of terrestrial telecommunications infrastructures in France, Italy, the United Kingdom, Spain, Poland, the Netherlands, Portugal, Switzerland, Denmark, Sweden, Ireland, and Austria. It operates through four segments: Towers; DAS, Small Cells, and RAN as a Service; Fiber, Connectivity, and Housing Services; and Broadcast. The Towers segment provides integrated network passive infrastructure services; other wireless telecommunications; and broadband network operators services, as well as colocation and engineering services. The DAS, Small Cells, and RAN as a Service segment offers services, such as RAN as a Service, which entails the emission and transmission active services; PPDR services comprising active infrastructure management for public administrations, including TETRA and 4G/LTE mission critical service networks; operation and maintenance; infrastructure support services; and other services that include smart cities/Internet of Things. The Fiber, Connectivity, and Housing Services segment provides data transport through fiber, including fibre-to-the-tower (FTTT), connectivity, backhaul transmission, and hosting services in edge data centers infrastructure. The broadcast segment engages in the distribution and transmission of television and radio signals; operation and maintenance of broadcasting networks; provision of connectivity for media content and over-the-top (OTT) broadcasting services; and other services, as well as offers coverage of the digital terrestrial television (DTT) services. The company also offers fixed and mobile telecommunication services; and provision of telecommunications equipment. In addition, it constructs and operates optic fiber telecommunications. The company was formerly known as Abertis Telecom Terrestre, S.A.U. and changed its name to Cellnex Telecom, S.A. in April 2015. Cellnex Telecom, S.A. was incorporated in 2008 and is headquartered in Madrid, Spain.

View company page →
▼ Acciones|GRIFOLS

Goes from 0.38% to 0.04%.

Grifols, S.A., together with its subsidiaries, engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally. It operates through four segments: Biopharma, Diagnostic, Bio Supplies, and Others. The company offers various hemoderivatives from human plasma for immunology, infectious diseases, hepatology, intensive care, pulmonology, hematology, and neurology treatment areas; and markets diagnostic testing equipment, reagents, and other equipment, as well as provides transfusion medicine, clinical diagnostics, and testing services. It also offers biological products, including albumin, albumin-derived products, immunoglobulins, thrombin, other proteins, and intermediate plasma products to pharma and biotech companies for biopharma use; and whole blood, blood components, processed plasma, and clinical samples to life-science research and in-vitro diagnostic companies for diagnostic use. In addition, the company provides healthcare solutions for hospitals, such as intravenous solutions to maintain or restore fluids and electrolyte balance in patients; high-tech solutions to automate hospital processes; clinical nutrition to deliver nutrition and medication; and medical devices comprising instrumentation and disposable materials for various hospital services, which include interventional neuroradiology, hemodynamics, urology, anesthesiology and cardiovascular surgery, as well as manufacturing services to third parties and research activities. Further, it is involved in engineering services; packaging, labelling, storage, distribution, manufacturing, and development of pharmaceutical products; import, export, and commercialization activities; travel agency services; reinsurance of insurance policies; support services; law business; and consultation, administration, and financing services. The company was founded in 1909 and is headquartered in Barcelona, Spain.

View company page →
▼ Acciones|HEINEKEN HOLDING NV

Goes from 0.34% to 0.04%.

Heineken Holding N.V., together with its subsidiaries, engages in brewing and selling beer and cider in the Netherlands, Europe, the Americas, Africa & Middle East, Asia Pacific and internationally. The company's portfolio consists of approximately 340 international, regional, local, and specialty beers and ciders. The company was founded in 1864 and is based in Amsterdam, the Netherlands. Heineken Holding N.V. is a subsidiary of L'Arche Green N.V.

View company page →

Fixed income

Declared FI exposure
995,264 €
% of portfolio
25.9%
Positions
5
Issuers
1
Sovereign: 995,264 € Corporate: 0 €

Maturity ladder

Observed contractual maturity of each position, repos excluded. Matured/≤3 months includes bonds maturing in the first days after the period close.

Matured or ≤3 months · 100.0%
Maturity Positions Exposure %
Matured or ≤3 months 5 995,264 € 100.0%
3-6 months 0 0 € 0.0%
6-12 months 0 0 € 0.0%
1-2 years 0 0 € 0.0%
2-5 years 0 0 € 0.0%
5-10 years 0 0 € 0.0%
> 10 years 0 0 € 0.0%
Unknown 0 0 € 0.0%

Top issuers

The 10 issuers with the largest declared exposure in this fund, repos excluded.

Issuer Type ISINs Exposure Next maturity
Reino de España Sovereign 2 995,264 € 2026-01-16

Top instruments

The 10 instruments with the largest declared exposure. No yield, IRR or rating: there's no reliable data to compute them.

ISIN Coupon Maturity Exposure
ES0L02602065 Reino de España 2.00% 2026-02-06 498,423 €
ES0L02601166 Reino de España 1.94% 2026-01-16 198,334 €
ES0L02601166 Reino de España 1.81% 2026-01-16 99,679 €
ES0L02601166 Reino de España 1.85% 2026-01-16 99,508 €
ES0L02601166 Reino de España 1.97% 2026-01-16 99,320 €

This period's fixed-income moves

Compares the current fixed-income portfolio with the previous period, by ISIN. An exit that coincides with maturity isn't a sale: the bond reached its contractual date.

New positions: 2 Exits at maturity: 6 Exits not explained by maturity: 0
+ ESTADO ESPAÑOL

Enters the portfolio at 12.98% weight.

+ ESTADO ESPAÑOL

Enters the portfolio at 2.59% weight.

◦ ESTADO ESPAÑOL

Leaves the portfolio; it was 2.67% of weight.

◦ ESTADO ESPAÑOL

Leaves the portfolio; it was 2.68% of weight.

◦ ESTADO ESPAÑOL

Leaves the portfolio; it was 2.67% of weight.

◦ ESTADO ESPAÑOL

Leaves the portfolio; it was 2.67% of weight.

◦ ESTADO ESPAÑOL

Leaves the portfolio; it was 2.67% of weight.

◦ ESTADO ESPAÑOL

Leaves the portfolio; it was 2.66% of weight.

Disclaimer

This is not financial advice. The portfolio comes from the periodic report the fund files with the CNMV and lags the real close of the period: it is a snapshot of the end of each half-year, not a real-time portfolio.